All-trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia

被引：15

作者：

Asou, Norio ^{[1
]}

机构：

[1] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 860, Japan

来源：

INTERNAL MEDICINE | 2007年 / 46卷 / 02期

关键词：

acute promyelocytic leukemia; differentiation therapy; molecular targeted therapy; retinoic acid syndrome;

D O I：

10.2169/internalmedicine.46.1780

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

收藏

页码：91 / 93

页数：3

相关论文

共 8 条

[1]

Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia [J].

Asou, N .

INTERNAL MEDICINE, 2005, 44 (08) :775-776

[2]

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy [J].

Asou, N ;

Adachi, K ;

Tamura, J ;

Kanamaru, A ;

Kageyama, S ;

Hiraoka, A ;

Omoto, E ;

Akiyama, H ;

Tsubaki, K ;

Saito, K ;

Kuriyama, K ;

Oh, H ;

Kitano, K ;

Miyawaki, S ;

Takeyama, K ;

Yamada, O ;

Nishikawa, K ;

Takahashi, M ;

Matsuda, S ;

Ohtake, S ;

Suzushima, H ;

Emi, N ;

Ohno, R .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :78-85

[3]

Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG) [J].

Asou, N ;

Adachi, K ;

Tamura, J ;

Kanamaru, A ;

Kageyama, S ;

Hiraoka, A ;

Omoto, E ;

Akiyama, H ;

Tsubaki, K ;

Saito, K ;

Kuriyama, K ;

Oh, H ;

Kitano, K ;

Miyawaki, S ;

Takeyama, K ;

Yamada, O ;

Nishikawa, K ;

Takahashi, M ;

Matsuda, S ;

Ohtake, S ;

Ohno, R .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (Suppl 1) :S65-S71

[4]

ASOU N, 2004, RINSHO KETSUEKI, V454, P115

[5]

USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA [J].

HUANG, ME ;

YE, YC ;

CHEN, SR ;

CHAI, JR ;

LU, JX ;

ZHOA, L ;

GU, LJ ;

WANG, ZY .

BLOOD, 1988, 72 (02) :567-572

[6]

ALL-TRANS-RETINOIC ACID FOR THE TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA [J].

KANAMARU, A ;

TAKEMOTO, Y ;

TANIMOTO, M ;

MURAKAMI, H ;

ASOU, N ;

KOBAYASHI, T ;

KURIYAMA, K ;

OHMOTO, E ;

SAKAMAKI, H ;

TSUBAKI, K ;

HIRAOKA, A ;

YAMADA, O ;

OH, H ;

SAITO, K ;

MATSUDA, S ;

MINATO, K ;

UEDA, T ;

OHNO, R .

BLOOD, 1995, 85 (05) :1202-1206

[7]

Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate [J].

Ohno, R ;

Asou, N ;

Ohnishi, K .

LEUKEMIA, 2003, 17 (08) :1454-1463

[8]

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE) .2. Clinical efficacy and pharmacokinetics in relapsed patients [J].

Shen, ZX ;

Chen, GQ ;

Ni, JH ;

Li, XS ;

Xiong, SM ;

Qiu, QY ;

Zhu, J ;

Tang, W ;

Sun, GL ;

Yang, KQ ;

Chen, Y ;

Zhou, L ;

Fang, ZW ;

Wang, YT ;

Ma, J ;

Zhang, P ;

Zhang, TD ;

Chen, SJ ;

Chen, Z ;

Wang, ZY .

BLOOD, 1997, 89 (09) :3354-3360